Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Bilypsa 4mg Tablets | 135-Count | POSACONAZOLE
Pharma

Bilypsa 4mg Tablets | 135-Count | POSACONAZOLE

$190

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse POSACONAZOLE — 4mg per tablet, 135-count pack. Extended-spectrum triazole antifungal for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients, and treatment of certain refractory fungal infections. Key warning: QT prolongation — caution with other QT drugs. Strong CYP3A4 inhibitor — multiple interactions. Hepatotoxicity monitoring. Suspension vs tablet have very different bioavailability characteristics.

SKU
VES-002274-BILYPSA-4MG-135TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Bilypsa 4mg (1X45) (POSACONAZOLE)?

Extended-spectrum triazole antifungal for prophylaxis of invasive Aspergillus and Candida infections in immunocompromised patients, and treatment of certain refractory fungal infections.

How it Works

Inhibits fungal lanosterol 14-alpha-demethylase (CYP51), blocking ergosterol synthesis. Broadest spectrum of any oral azole — covers Zygomycetes (mucormycosis) unlike other azoles.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
POSACONAZOLE
Dose per Tablet
4MG
Pack Size
135 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Nausea, vomiting, diarrhea, headache, elevated liver enzymes, QT prolongation, hypokalemia.

Safety Warnings

QT prolongation — caution with other QT drugs. Strong CYP3A4 inhibitor — multiple interactions. Hepatotoxicity monitoring. Suspension vs tablet have very different bioavailability characteristics. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.